AZD5153 6-Hydroxy-2-naphthoic acid
CAS No. 1869912-40-2
AZD5153 6-Hydroxy-2-naphthoic acid ( AZD 5153 6-Hydroxy-2-naphthoic acid;AZD-5153 6-Hydroxy-2-naphthoic acid )
Catalog No. M12891 CAS No. 1869912-40-2
A potent, selective, bivalent and orally available BET/BRD4 bromodomain with IC50 of 5 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 116 | In Stock |
|
10MG | 201 | In Stock |
|
25MG | 431 | In Stock |
|
50MG | 622 | In Stock |
|
100MG | 885 | In Stock |
|
500MG | 1764 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAZD5153 6-Hydroxy-2-naphthoic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, bivalent and orally available BET/BRD4 bromodomain with IC50 of 5 nM.
-
DescriptionA potent, selective, bivalent and orally available BET/BRD4 bromodomain with IC50 of 5 nM; simultaneously binds to two bromodomains in BRD4; exhibits antitumor activity in multiple xenograft models of acute myeloid leukemia, multiple myeloma, and diffuse large B cell lymphoma.
-
SynonymsAZD 5153 6-Hydroxy-2-naphthoic acid;AZD-5153 6-Hydroxy-2-naphthoic acid
-
PathwayChromatin/Epigenetic
-
TargetBromodomain
-
RecptorBD1-BRD4;FL-BRD4
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1869912-40-2
-
Formula Weight667.75
-
Molecular FormulaC36H41N7O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 34 mg/mL
-
SMILESCC1C(=O)N(CCN1CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5OC)C=C4)C.C1=CC2=C(C=CC(=C2)O)C=C1C(=O)O
-
Chemical Name2-Naphthalenecarboxylic acid, 6-hydroxy-, compd. with (3R)-4-[2-[4-[1-(3-methoxy-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-4-piperidinyl]phenoxy]ethyl]-1,3-dimethyl-2-piperazinone (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bradbury RH, et al. J Med Chem. 2016 Sep 8;59(17):7801-17.
2. Rhyasen GW, et al. Mol Cancer Ther. 2016 Nov;15(11):2563-2574.
3. Collins TA, et al. CPT Pharmacometrics Syst Pharmacol. 2017 Jun;6(6):357-364.
2. Rhyasen GW, et al. Mol Cancer Ther. 2016 Nov;15(11):2563-2574.
3. Collins TA, et al. CPT Pharmacometrics Syst Pharmacol. 2017 Jun;6(6):357-364.
molnova catalog
related products
-
FL-411
FL-411 is a novel small-molecule inhibitor of BRD4.
-
ABBV-744
ABBV-744 (ABBV744) is a potent, BDII-selective BET bromodomain inhibitor.
-
JQ-1 carboxylic acid
JQ-1 carboxylic acid is an inhibitor of bromodomain and extra terminal domain (BET) family proteins.